Novare Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $13.3M | Sell |
110,477
-2,629
| -2% | -$304K | 1.05% | 28 |
|
|
2025
Q4 | $11.9M | Buy |
113,106
+1,322
| +1% | +$124K | 0.89% | 37 |
|
|
2025
Q3 | $9.38M | Sell |
111,784
-8,480
| -7% | -$698K | 0.71% | 52 |
|
|
2025
Q2 | $9.52M | Sell |
120,264
-76,476
| -39% | -$6.08M | 0.77% | 48 |
|
|
2025
Q1 | $17.7M | Buy |
196,740
+2,128
| +1% | +$199K | 1.54% | 19 |
|
|
2024
Q4 | $19.4M | Buy |
194,612
+6,447
| +3% | +$665K | 1.63% | 17 |
|
|
2024
Q3 | $21.4M | Buy |
188,165
+22,077
| +13% | +$2.62M | 1.81% | 13 |
|
|
2024
Q2 | $20.6M | Sell |
166,088
-4,031
| -2% | -$519K | 1.85% | 12 |
|
|
2024
Q1 | $22.4M | Buy |
170,119
+7,656
| +5% | +$944K | 2.03% | 12 |
|
|
2023
Q4 | $17.7M | Buy |
162,463
+7,608
| +5% | +$790K | 1.8% | 14 |
|
|
2023
Q3 | $15.9M | Buy |
154,855
+5,960
| +4% | +$642K | 1.8% | 12 |
|
|
2023
Q2 | $17.2M | Sell |
148,895
-1,102
| -0.7% | -$125K | 1.85% | 11 |
|
|
2023
Q1 | $16M | Sell |
149,997
-18,884
| -11% | -$2.04M | 1.81% | 10 |
|
|
2022
Q4 | $18.7M | Sell |
168,881
-5,385
| -3% | -$550K | 2.21% | 7 |
|
|
2022
Q3 | $15M | Buy |
174,266
+12,517
| +8% | +$1.12M | 1.92% | 9 |
|
|
2022
Q2 | $14.7M | Buy |
161,749
+55,123
| +52% | +$4.89M | 1.82% | 10 |
|
|
2022
Q1 | $8.75M | Buy |
106,626
+4,448
| +4% | +$351K | 0.93% | 42 |
|
|
2021
Q4 | $7.83M | Buy |
102,178
+2,903
| +3% | +$231K | 0.79% | 58 |
|
|
2021
Q3 | $7.46M | Buy |
99,275
+5,430
| +6% | +$413K | 0.83% | 57 |
|
|
2021
Q2 | $7.3M | Buy |
93,845
+89,294
| +1,962% | +$6.64M | 0.82% | 61 |
|
|
2021
Q1 | $335K | Sell |
4,551
-311
| -6% | -$22.9K | 0.04% | 117 |
|
|
2020
Q4 | $379K | Sell |
4,862
-99
| -2% | -$7.57K | 0.05% | 107 |
|
|
2020
Q3 | $393K | Buy |
4,961
+348
| +8% | +$27.3K | 0.06% | 108 |
|
|
2020
Q2 | $340K | Sell |
4,613
-1,228
| -21% | -$92.4K | 0.05% | 113 |
|
|
2020
Q1 | $429K | Buy |
5,841
+1,237
| +27% | +$97.2K | 0.08% | 110 |
|
|
2019
Q4 | $400K | Buy |
4,604
+1,093
| +31% | +$89.8K | 0.06% | 124 |
|
|
2019
Q3 | $282K | Buy |
3,511
+48
| +1% | +$3.85K | 0.04% | 128 |
|
|
2019
Q2 | $277K | Hold |
3,463
| – | – | 0.04% | 125 |
|
|
2019
Q1 | $275K | Sell |
3,463
-62
| -2% | -$4.64K | 0.04% | 127 |
|
|
2018
Q4 | $257K | Buy |
3,525
+1
| +0% | +$71 | 0.05% | 130 |
|
|
2018
Q3 | $239K | Sell |
3,524
-106
| -3% | -$6.75K | 0.04% | 137 |
|
|
2018
Q2 | $210K | Sell |
3,630
-2,685
| -43% | -$151K | 0.04% | 148 |
|
|
2018
Q1 | $328K | Sell |
6,315
-68
| -1% | -$3.67K | 0.06% | 130 |
|
|
2017
Q4 | $343K | Buy |
6,383
+136
| +2% | +$7.54K | 0.06% | 127 |
|
|
2017
Q3 | $382K | Buy |
6,247
+2,104
| +51% | +$128K | 0.07% | 129 |
|
|
2017
Q2 | $253K | Sell |
4,143
-4,291
| -51% | -$261K | 0.06% | 107 |
|
|
2017
Q1 | $511K | Sell |
8,434
-289
| -3% | -$17.5K | 0.12% | 92 |
|
|
2016
Q4 | $490K | Buy |
8,723
+152
| +2% | +$8.9K | 0.12% | 90 |
|
|
2016
Q3 | $510K | Buy |
8,571
+3,793
| +79% | +$222K | 0.13% | 90 |
|
|
2016
Q2 | $263K | Sell |
4,778
-5,054
| -51% | -$269K | 0.07% | 99 |
|
|
2016
Q1 | $496K | Sell |
9,832
-929
| -9% | -$45.5K | 0.14% | 90 |
|
|
2015
Q4 | $542K | Sell |
10,761
-711
| -6% | -$35.8K | 0.15% | 92 |
|
|
2015
Q3 | $541K | Buy |
11,472
+7,103
| +163% | +$377K | 0.15% | 90 |
|
|
2015
Q2 | $237K | Sell |
4,369
-1,168
| -21% | -$65.5K | 0.06% | 101 |
|
|
2015
Q1 | $304K | Buy |
5,537
+91
| +2% | +$5.15K | 0.08% | 99 |
|
|
2014
Q4 | $295K | Sell |
5,446
-34
| -0.6% | -$1.89K | 0.07% | 101 |
|
|
2014
Q3 | $310K | Buy |
5,480
+210
| +4% | +$11.8K | 0.08% | 106 |
|
|
2014
Q2 | $291K | Buy |
5,270
+406
| +8% | +$22.1K | 0.07% | 110 |
|
|
2014
Q1 | $263K | Buy |
4,864
+518
| +12% | +$26.8K | 0.07% | 109 |
|
|
2013
Q4 | $208K | Buy |
+4,346
| New | +$199K | 0.06% | 118 |
|
Other funds holding MRK
VCM
VPM
Novare Capital Management's MRK Position: Q1 2026 in Review
Novare Capital Management reduced its Merck (MRK) stake by 2.3% in Q1 2026, selling an estimated $304K and leaving 110,477 shares worth $13.3M. The position accounts for 1.05% of the portfolio, ranked #28.
Novare Capital Management first reported a position in MRK in Q4 2013 and has held it in 50 quarters since. The position peaked at $22.4M in Q1 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Novare Capital Management held 110,477 shares of Merck worth $13.3M as of Q1 2026.
- Novare Capital Management sold 2,629 Merck shares in Q1 2026, an estimated $304K.
- Merck made up 1.05% of Novare Capital Management's portfolio in Q1 2026, its #28 holding.
- Novare Capital Management first reported a position in Merck in Q4 2013 and has held it in 50 quarters since.
- Novare Capital Management's Merck position peaked at $22.4M in Q1 2024.
- 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Novare Capital Management's 13F filing for Q1 2026, filed 17 Apr 2026.